The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Real-World Safety and Effectiveness of Omalizumab in Moderate to Severe Allergic Asthma Patients in China: A Post-Authorization Study
|
|---|---|
| Published in |
Journal of Asthma and Allergy, June 2023
|
| DOI | 10.2147/jaa.s406628 |
| Pubmed ID | |
| Authors |
Nan Su, Lili Zhi, Fengxia Liu, Yongsheng Wang, Qingling Zhang, Xiansheng Liu, Xueyan Wang, Guodong Hao, Xiuqin Zhang, Qiang Hu, Monica Ligueros-Saylan, Alkaz Uddin, Jing Yang, Tiantian Liang, Liju Ding, Runqin Li, Chen Wang |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 June 2023.
All research outputs
#15,726,395
of 23,971,017 outputs
Outputs from Journal of Asthma and Allergy
#321
of 493 outputs
Outputs of similar age
#148,100
of 282,953 outputs
Outputs of similar age from Journal of Asthma and Allergy
#6
of 13 outputs
Altmetric has tracked 23,971,017 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 493 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,953 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.